Financials Lepu Medical Technology (Beijing) Co., Ltd.

Equities

300003

CNE100000H44

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 03:30:00 21/06/2024 am IST 5-day change 1st Jan Change
15.78 CNY -0.50% Intraday chart for Lepu Medical Technology (Beijing) Co., Ltd. -1.99% -2.35%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 58,527 48,711 40,557 42,506 30,095 29,314 - -
Enterprise Value (EV) 1 61,854 51,615 41,476 41,218 30,515 25,559 24,744 23,704
P/E ratio 33.9 x 26.8 x 23.8 x 18.9 x 23.9 x 14.8 x 12.8 x 11.1 x
Yield 0.6% 0.84% 1.22% 1.48% 2.05% 2.23% 2.34% 2.74%
Capitalization / Revenue 7.51 x 6.06 x 3.8 x 4.01 x 3.77 x 3.3 x 2.89 x 2.54 x
EV / Revenue 7.93 x 6.42 x 3.89 x 3.89 x 3.82 x 2.87 x 2.44 x 2.05 x
EV / EBITDA 27.1 x 19.9 x 15.9 x 13.2 x 14.6 x 8.57 x 7.4 x 6.22 x
EV / FCF 4,31,29,841 x 3,36,42,681 x 1,99,43,434 x 2,18,30,981 x - - - -
FCF Yield 0% 0% 0% 0% - - - -
Price to Book 7.88 x 4.97 x 3.63 x 2.89 x 1.93 x 1.69 x 1.53 x 1.36 x
Nbr of stocks (in thousands) 17,69,250 17,92,178 17,92,178 18,50,513 18,62,337 18,57,638 - -
Reference price 2 33.08 27.18 22.63 22.97 16.16 15.78 15.78 15.78
Announcement Date 21/02/20 26/02/21 25/04/22 25/04/23 19/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,796 8,039 10,660 10,609 7,980 8,893 10,153 11,558
EBITDA 1 2,286 2,592 2,610 3,112 2,084 2,982 3,346 3,810
EBIT 1 1,961 2,149 2,145 2,623 1,547 2,466 2,838 3,294
Operating Margin 25.16% 26.74% 20.12% 24.72% 19.39% 27.73% 27.95% 28.5%
Earnings before Tax (EBT) 1 2,063 2,203 2,146 2,612 1,554 2,439 2,820 3,281
Net income 1 1,725 1,802 1,719 2,203 1,258 1,991 2,300 2,664
Net margin 22.13% 22.42% 16.13% 20.76% 15.77% 22.38% 22.65% 23.04%
EPS 2 0.9746 1.014 0.9510 1.212 0.6757 1.065 1.229 1.426
Free Cash Flow 1,434 1,534 2,080 1,888 - - - -
FCF margin 18.4% 19.09% 19.51% 17.8% - - - -
FCF Conversion (EBITDA) 62.73% 59.18% 79.69% 60.66% - - - -
FCF Conversion (Net income) 83.12% 85.14% 120.96% 85.71% - - - -
Dividend per Share 2 0.2000 0.2280 0.2750 0.3410 0.3314 0.3523 0.3692 0.4323
Announcement Date 21/02/20 26/02/21 25/04/22 25/04/23 19/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,025 2,784 2,428 2,848 2,437 1,864 1,958 1,721 1,922 2,279 2,518 2,208 2,080 -
EBITDA - - - - - - - - - - - - - -
EBIT 1 -244.2 847 624 467.7 699.8 413.8 417.8 15.73 609.2 643.7 697.6 601.1 590.3 -
Operating Margin -12.06% 30.42% 25.7% 16.42% 28.72% 22.2% 21.34% 0.91% 31.7% 28.24% 27.71% 27.23% 28.38% -
Earnings before Tax (EBT) 1 - - - - - 414.9 - -18.39 - 585.9 661.2 462.9 - -
Net income 1 - - - - - 364.6 - -95.4 - 487 549.6 404.9 - -
Net margin - - - - - 19.56% - -5.54% - 21.37% 21.83% 18.34% - -
EPS 2 -0.1000 0.4000 0.3100 0.2000 0.3177 0.1900 0.2200 -0.0500 0.2585 0.2706 0.3024 0.2586 0.2600 -
Dividend per Share 2 - - - 0.3410 - - - - - - - 0.4070 - -
Announcement Date 25/04/22 26/08/22 27/10/22 25/04/23 25/04/23 25/08/23 25/10/23 19/04/24 19/04/24 - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,327 2,904 919 - 420 - - -
Net Cash position 1 - - - 1,288 - 3,755 4,569 5,610
Leverage (Debt/EBITDA) 1.455 x 1.12 x 0.3521 x - 0.2015 x - - -
Free Cash Flow 1,434 1,534 2,080 1,888 - - - -
ROE (net income / shareholders' equity) 25% 21.1% 16% 17.6% 8.23% 11.3% 11.8% 12.1%
ROA (Net income/ Total Assets) 11.1% 11.1% 8.85% 9.75% 4.54% 7.6% 7.9% -
Assets 1 15,520 16,246 19,428 22,591 27,731 26,191 29,109 -
Book Value Per Share 2 4.200 5.470 6.240 7.940 8.380 9.350 10.30 11.60
Cash Flow per Share 2 1.120 1.160 1.700 1.480 0.5300 1.400 1.430 1.680
Capex 1 556 555 982 903 836 872 897 940
Capex / Sales 7.13% 6.91% 9.22% 8.51% 10.48% 9.81% 8.84% 8.13%
Announcement Date 21/02/20 26/02/21 25/04/22 25/04/23 19/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
15.78 CNY
Average target price
20.27 CNY
Spread / Average Target
+28.47%
Consensus
  1. Stock Market
  2. Equities
  3. 300003 Stock
  4. Financials Lepu Medical Technology (Beijing) Co., Ltd.